Biotechnology & Life Sciences
Brain-Interface | Genetics & DNA | Longevity
Friday, 19 June 2026
09:30 – 13:00
Stage 3
Rapid advances across the organic and synthetic biological chain are fundamentally changing the definition of humanity today. With artificial intelligence rapidly discovering new proteins and supporting the decoding of human DNA, a genetically-engineered future becomes possible. Recent advances in genetic therapies as well used of mRNA therapies open new vistas in treatment of cancer and other diseases. And the human trials progress of brain interface companies such as Neuralink hold up the promise of revolutionary changes in rehabilitation and synthetic implants.
Keynote Speech
09:30 – 10:00
Session 1: The Health Revolution
10:00 – 11:30
This panel will examine the revolutions taking place in human health. We will focus on three subjects:
-
Longevity
-
The Brain-Interface Revolution
-
The Genetic Revolution
Speakers will examine issues of increasing the human lifespan; changing cell biology to reduce or reverse aging; new advances in brain-interface revolution; and the tremendous advances taking place as a result of artificial intelligence and genetic sequencing.
4 Speakers
Session 2: Investing In & Regulating Healthtech
11:30 – 13:00
This session explores the role of public regulation of life sciences and associated technology. It takes into account the regulatory approaches of the European Union and the United States, and provides an overview of risks and opportunities in this sector. It will also feature presentations by two investors in health tech to understand current investment trends and priorities as well as the role of regulation in investment.
4 Speakers